MedWatch

19 Novo executives to testify in Danish market manipulation case

A group of investors who demand DKK 11.8 billion in compensation from Novo Nordisk plans to summon 19 former and current Novo executives and a whistleblower as witnesses in the case.

Former CEO of Novo Nordisk Lars Rebien Sørensen (in focus), CEO Lars Fruergaard Jørgensen (middle) and former chairman Göran Ando (front) are all called in as witnesses in the case. Photo: Søren Bidstrup / Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles